Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The microbial cytoplasmic membrane phospholipid bilayer is a complex, essential structure that serves as the primary boundary between the cytoplasm and the external environment in both bacteria and fungi [1.3.1]. In bacteria, this membrane is the site of vital processes including oxidative phosphorylation, ATP synthesis, and the transport of nutrients and waste [1.1.1, 1.3.1]. In fungi, the bilayer is characterized by the presence of ergosterol, which maintains membrane fluidity and structural integrity [1.2.1, 1.2.2]. This structure is a major therapeutic target because its physical disruption leads to an immediate loss of cellular homeostasis and bactericidal or fungicidal effects [1.1.4, 1.3.1]. Drugs such as polymyxins and daptomycin target the bacterial membrane by inducing depolarization or physical damage, while polyene antifungals like amphotericin B bind to ergosterol to create lethal pores [1.1.4, 1.2.1, 1.5.4]. However, the high degree of structural similarity between microbial and mammalian membranes often leads to significant safety concerns, such as nephrotoxicity and neurotoxicity, particularly when drugs lack sufficient selectivity for microbial lipids over host cholesterol [1.5.1, 1.5.3].
Disruption of membrane integrity through pore formation, depolarization, or detergent-like effects, leading to the leakage of essential intracellular components and rapid cell death.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cytoplasmic membrane phospholipid bilayer.